Page last updated: 2024-09-03

omega-n-methylarginine and enalaprilat anhydrous

omega-n-methylarginine has been researched along with enalaprilat anhydrous in 10 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(enalaprilat anhydrous)
Trials
(enalaprilat anhydrous)
Recent Studies (post-2010) (enalaprilat anhydrous)
4,41134433684610976

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)enalaprilat anhydrous (IC50)
Angiotensin-converting enzymeMus musculus (house mouse)0.0115
Angiotensin-converting enzyme Homo sapiens (human)0.2405
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.0054
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0012
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.0036
Angiotensin-converting enzyme 2 Homo sapiens (human)0.0024

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (70.00)18.2507
2000's3 (30.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arakawa, N; Funakoshi, T; Hiramori, K; Nakamura, M; Suzuki, T; Yoshida, H1
Anania, V; Demontis, MP; Madeddu, P; Manunta, P; Parpaglia, PP; Pazzola, A; Soro, A; Tonolo, G; Troffa, C; Varoni, MV1
Arakawa, N; Funakoshi, T; Hiramori, K; Makita, S; Nakamura, M; Yoshida, H1
Fujikura, H; Hasegawa, Y; Ishii, Y; Sekiguchi, N; Takayanagi, I1
Egashira, K; Hirakawa, Y; Kuga, T; Mohri, M; Shimokawa, H; Tagawa, T; Takeshita, A1
Blaschke, TF; Chalon, S; Hoffman, BB; Moreno, H1
Husain, S; Prasad, A; Quyyumi, AA1
Egashira, K; Mohri, M; Tagawa, H; Takeshita, A1
Carlsson, PO; Hellerström, C; Iwase, M; Jansson, L; Sandler, S1
Fetics, B; Hare, JM; Kass, DA; Maughan, WL; Pak, PH; Wittstein, IS1

Trials

2 trial(s) available for omega-n-methylarginine and enalaprilat anhydrous

ArticleYear
Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
    Journal of the American College of Cardiology, 1994, Nov-01, Volume: 24, Issue:5

    Topics: Acetylcholine; Arginine; Aspirin; Enalaprilat; Endothelium, Vascular; Female; Forearm; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Plethysmography; Premedication; Vasodilation

1994
Effect of enalaprilat on nitric oxide activity in coronary artery disease.
    The American journal of cardiology, 1999, Jul-01, Volume: 84, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Female; Femoral Artery; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Reproducibility of Results; Vascular Resistance; Vasodilation

1999

Other Studies

8 other study(ies) available for omega-n-methylarginine and enalaprilat anhydrous

ArticleYear
Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:6

    Topics: Acetylcholine; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Aspirin; Drug Synergism; Enalaprilat; Endothelium, Vascular; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vascular Resistance; Vasodilation

1992
Endothelin-1-induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1991, Volume: 14, Issue:6

    Topics: Animals; Arginine; Blood Pressure; Enalaprilat; Endothelins; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction

1991
Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
    General pharmacology, 1993, Volume: 24, Issue:3

    Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arginine; Bradykinin; Enalaprilat; Endothelium, Vascular; Guinea Pigs; Ileum; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; omega-N-Methylarginine; Rats; Rats, Wistar

1993
Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
    Journal of the American College of Cardiology, 1997, Volume: 30, Issue:1

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Coronary Angiography; Coronary Disease; Coronary Vessels; Enalaprilat; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Ultrasonography, Doppler; Ultrasonography, Interventional; Vasodilation

1997
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
    Clinical pharmacology and therapeutics, 1999, Volume: 65, Issue:3

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Chronic Disease; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Smoking; Vasodilation; Vasodilator Agents; Veins

1999
Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Coronary Vessels; Drug Interactions; Enalaprilat; Enzyme Inhibitors; Female; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Tachycardia; Vasodilation; Vasodilator Agents

2000
The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production.
    European journal of endocrinology, 2001, Volume: 144, Issue:2

    Topics: Adrenergic alpha-Antagonists; Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; DNA; Enalaprilat; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Insulin; Islets of Langerhans; omega-N-Methylarginine; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY

2001
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Journal of the American College of Cardiology, 2001, Volume: 38, Issue:2

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Compliance; Depression, Chemical; Diastole; Dobutamine; Enalaprilat; Enzyme Inhibitors; Female; Heart; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Ventricular Dysfunction, Left

2001